Clinical Evaluation of Lava Digital Veneer System (DVS) Crowns
Launched by SOLVENTUM US LLC · Jan 18, 2011
Trial Information
Current as of May 05, 2025
Terminated
Keywords
ClinConnect Summary
Veneers will be randomly allocated to study crowns. Study crowns will be evaluated over three years. The test porcelain veneer is CAD/CAM milled as a veneer shell that is then fused to the CAD/CAM milled Lava crown to make the final crown to be cemented in the patient's mouth. This may be a more predictable technique in the fabrication of Lava crowns than current conventional methods.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Over 18 years of age.
- • Have at least one decayed back tooth in need of a crown
- • Study tooth to be an upper or lower premolar or molar tooth/ teeth
- • Study tooth to be vital and asymptomatic at start of study
- Exclusion Criteria:
- • Teeth which are non vital, have had root canal treatment
- • Teeth which are pulp capped
- • Sensitive teeth
- • Significant untreated dental disease including periodontitis and rampant decay
- • Pregnant or lactating women
- • Patients with allergies to any of the materials to be used in the study
- • Unable to attend the recall appointments
About Solventum Us Llc
Solventum US LLC is a dedicated clinical trial sponsor focused on advancing innovative therapeutic solutions through rigorous research and development. With a commitment to improving patient outcomes, the company specializes in conducting high-quality clinical trials across various therapeutic areas, leveraging cutting-edge technology and methodologies. Solventum US LLC collaborates with leading healthcare professionals and institutions to ensure the highest standards of safety and efficacy in its studies, ultimately aiming to bring transformative treatments to market. Through its strategic approach and emphasis on scientific integrity, Solventum US LLC plays a vital role in the evolution of modern medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ann Arbor, Michigan, United States
Patients applied
Trial Officials
Dennis Fasbinder, DDS
Principal Investigator
Univ of Michigan School of Dentistry
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials